Alere Diagnostics

Name: Central Jersey Urgent Care
Price range: $

Walk-In Diagnostics & Drug Testing in Browns Mills, NJ

Central Jersey Urgent Care is proud to offer Electronic Chain of Custody (eCCF®) for DOT drug screenings through a partnership with Alere Laboratories. By processing DOT drug tests electronically, employers and employees can skip the hassle and headache of paperwork, and ensure a safer workplace for all. Alere’s state-of-the-art technology reduces costs, boosts efficiency, and enables consistency in and across the workforce.

Alere toxicology offers computer-automated services for:

Urine Testing
Oral Fluid Testing
Hair Testing
Breath Alcohol Screening

Alere’s pre-employment and random drug testing services make safety, simple. Our comprehensive tools and technology are second to none for Occupational Health and Employer Services in Browns Mills, NJ.

Drug testing and management software
Online event scheduling
DOT compliance reports
Instant electronic DOT MIS reports
Expired event notification with automatic reporting of results

For more information about Alere and Central Jersey Urgent Care, contact us at (609) 757-1717.

Stop in to learn more about our trusted and reliable drug testing services in Burlington County, NJ. We are located at 6 Earlin Av, in Browns Mills, NJ 08015.

Get your latest COVID-19 and FLU/RSV Test Results

Please search for your test results in order to print them.

Testing Information

Your test was performed using one of the machines below:

Genesis Laboratory
Testing was performed using either of the following machines Thermo Fisher TaqMan 2019-nCoV Assay Kit v1, TaqMan 2019-nCoV Control Kit v1 Test, TaqPath COVID-19 Combo Kit and/ or Panther Fusion®️ SARS-CoV-2 Assay Kit. Positive results do not rule out co-infection with organisms not included in the Thermo Fisher TaqMan 2019-nCoV Assay Kit v1 and TaqMan 2019-nCoV Control Kit v1, TaqPath COVID-19 Combo Kit and/ or Panther Fusion®️ SARS-CoV-2 Assay Kit. The agent detected may not be the definite cause of this disease. This assay is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA). This test is only authorized for the duration of time of the declaration and for the detection of SARSCoV-2 RNS virus and/or diagnosis of COVID-19 infection under section 564 (b)(1) of the act, 21 U.S.C.360bbb-3(b)(1) unless the authorization is terminated or revoked sooner.
Clarity Laboratory
Virokey SARS CoV-2 real time PCR assay for detection of SARS CoV-2 from nasopharyngeal and oropharyngeal specimen was developed and its performance characteristics determined by Clarity Labs. The EUA approval #EU201790. This test is approved by CLIA, NJDOH and NYDOH. This test has been validated in accordance to FDA’s guidance document:”Policy for Diagnosis testing in laboratory verified to perform High complexity testing under CLIA prior to Emergency Use Authorization for Coronavirus disease-2019 during the public health emergency issued on February 29th 2020”. Negative results for symptomatic patients does not rule out the possibility of other bacterial or viral infections. Negative results does not rule out possibility of prior viral exposure. When Flag AB: Abnormal

NOTE: Results are uploaded each night, so if you don't see the results, try again tomorrow morning. If you have not found the test results after 5 days, please contact our office at (732) 781-0244 and select the office you tested.